-
August 19, 2022 Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine CollapsesThe psychedelic renaissance hits a rough patch as major companies look to tighten their belts...
-
August 18, 2022 Chris Rock Really Likes PsychedelicsThe comedian openly discusses using psychedelic mushrooms and hosting ayahuasca ceremonies at his home
-
August 17, 2022 California’s Cowardly Politicians Gut Psychedelic Decriminalization BillThe California legislature had the power to act on psychedelic decriminalization, but instead decided to...
-
August 15, 2022 MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts PipelineMindMed drops its proprietary ibogaine for opioid addiction research amidst an ongoing shakeup. What is...
-
August 11, 2022 An Inside Look into Field Trip’s Next-Generation Psychedelic, FT-104Field Trip is the only company exploring the therapeutic potential of a 4-HO-DiPT prodrug called...
-
August 10, 2022 Compass Pathways Sued for Stealing Trade SecretsCompass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual...
-
August 8, 2022 Three Phase 3 Clinical Trials that Could Legalize PsychedelicsThe road to psychedelic legalization has many paths. These 3 clinical trials have the best...
-
August 4, 2022 How to Smoke DMT for Beginners in 5 Easy StepsPeople who smoke DMT describe an intense and profound psychedelic experience, but there's a trick...
-
August 3, 2022 The Top 5 Psychedelics PodcastsNew psychedelic podcasts are popping up every week, but which ones are worth listening to?...
-
July 29, 2022 The Real Reason Cybin Bought Entheon’s DMT Clinical TrialIn a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical....
